Susceptibility genes for gentamicin-induced vestibular dysfunction

Stephen M Roth1, Scott M Williams, Lan Jiang

  • 1Department of Kinesiology, School of Public Health, University of Maryland, College Park, MD 20742-2611, USA. sroth1@umd.edu

Abstract

Insights

Gentamicin (GM) antibiotic use can cause vestibular ototoxicity. Genetic variations in NOS3, GSTZ1, and GSTP1 genes increase susceptibility to GM-induced balance dysfunction, particularly in carriers of specific risk alleles.

Area of Science:

  • Pharmacogenomics
  • Neuroscience
  • Genetics

Background:

  • Gentamicin (GM), an aminoglycoside antibiotic, can cause vestibular ototoxicity in approximately 5% of patients, leading to balance dysfunction.
  • Identifying genetic factors influencing susceptibility to GM-induced ototoxicity is crucial for personalized medicine and risk mitigation.

Purpose of the Study:

  • To identify specific gene polymorphisms associated with gentamicin-induced vestibular dysfunction.
  • To explore gene-gene interactions that may predict susceptibility to this adverse drug reaction.

Main Methods:

  • A case/control study design was employed, comparing patients with GM-induced vestibular dysfunction (cases) to healthy controls.
  • DNA from 137 cases and 126 controls was genotyped for 15 polymorphisms in 9 candidate genes, focusing on those involved in oxidative stress pathways.
  • Statistical analyses included single-gene association tests and multi-dimensionality reduction (MDR) to identify gene-gene interactions.

Main Results:

  • The NOS3 (ENOS) p.Glu298Asp polymorphism was significantly associated with GM-induced vestibular dysfunction (p ≤ 0.03).
  • A three-gene combination (NOS3, GSTZ1, GSTP1) using MDR analysis demonstrated the highest predictive accuracy (64%, p=0.009) for GM-induced vestibular dysfunction.

Conclusions:

  • Genetic variations in oxidative stress-related genes, specifically NOS3, GSTZ1, and GSTP1, are linked to increased susceptibility to gentamicin-induced vestibular ototoxicity.
  • Carriers of risk alleles in these genes may be at higher risk for developing balance dysfunction after GM administration.

Related Concept Videos

Equilibrium and Balance01:15

Equilibrium and Balance

The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
The Vestibular System01:29

The Vestibular System

The vestibular system is a set of inner ear structures that provide a sense of balance and spatial orientation. This system is comprised of structures within the labyrinth of the inner ear, including the cochlea and two otolith organs—the utricle and saccule. The labyrinth also contains three semicircular canals—superior, posterior, and horizontal—that are oriented on different planes.
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...